Institutional Fund
Armistice Capital, LLC
New York, NYCIK 16010865 filings on record
Portfolio Value
$3.03B
Q1 2026
Holdings
251
Reported positions
New Buys
102
Opened this quarter
QoQ Change
-25.8%
from $4.08B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Travere Therapeutics Inc4.8%
- Ptc Therapeutics Inc4.7%
- Madrigal Pharmaceuticals Inc4.6%
- Supernus Pharmaceuticals Inc3.2%
- Neurocrine Biosciences Inc3.1%
- Agios Pharmaceuticals Inc3.0%
- Other76.5%
Portfolio Holdings
251 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Travere Therapeutics Inc | 4.90M | $145.50M | 4.8% | +1.13M | Added |
| 2 | Ptc Therapeutics Inc | 2.07M | $141.33M | 4.7% | −727.4K | Reduced |
| 3 | Madrigal Pharmaceuticals Inc | 264.6K | $138.50M | 4.6% | −1.1K | Reduced |
| 4 | Supernus Pharmaceuticals Inc | 1.90M | $97.97M | 3.2% | −868.7K | Reduced |
| 5 | Neurocrine Biosciences Inc | 724.0K | $95.38M | 3.1% | −96.2K | Reduced |
| 6 | Agios Pharmaceuticals Inc | 2.72M | $91.88M | 3.0% | −320.0K | Reduced |
| 7 | Immunovant Inc | 3.56M | $88.55M | 2.9% | −2.18M | Reduced |
| 8 | Freshpet Inc | 1.09M | $64.46M | 2.1% | −202.7K | Reduced |
| 9 | Incyte Corp | 656.8K | $61.82M | 2.0% | −441.3K | Reduced |
| 10 | Dyne Therapeutics Inc | 3.18M | $57.56M | 1.9% | −74.6K | Reduced |
241 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio